150 related articles for article (PubMed ID: 27760926)
1. [Roles of lipoprotein and apolipoprotein in HCV infection].
Fukuhara T; Matsuura Y
Uirusu; 2015; 65(2):269-276. PubMed ID: 27760926
[TBL] [Abstract][Full Text] [Related]
2. Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus.
Fukuhara T; Ono C; Puig-Basagoiti F; Matsuura Y
Trends Microbiol; 2015 Oct; 23(10):618-629. PubMed ID: 26433694
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection and lipoprotein metabolism.
Aizawa Y; Seki N; Nagano T; Abe H
World J Gastroenterol; 2015 Sep; 21(36):10299-313. PubMed ID: 26420957
[TBL] [Abstract][Full Text] [Related]
4. Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae.
Fukuhara T; Tamura T; Ono C; Shiokawa M; Mori H; Uemura K; Yamamoto S; Kurihara T; Okamoto T; Suzuki R; Yoshii K; Kurosu T; Igarashi M; Aoki H; Sakoda Y; Matsuura Y
PLoS Pathog; 2017 Jun; 13(6):e1006475. PubMed ID: 28644867
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus relies on lipoproteins for its life cycle.
Grassi G; Di Caprio G; Fimia GM; Ippolito G; Tripodi M; Alonzi T
World J Gastroenterol; 2016 Feb; 22(6):1953-65. PubMed ID: 26877603
[TBL] [Abstract][Full Text] [Related]
6. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
7. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
8. Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.
Yang Z; Wang X; Chi X; Zhao F; Guo J; Ma P; Zhong J; Niu J; Pan X; Long G
J Virol; 2016 Nov; 90(21):9632-9643. PubMed ID: 27535051
[TBL] [Abstract][Full Text] [Related]
9. HCV Assembly and Egress via Modifications in Host Lipid Metabolic Systems.
Shimotohno K
Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 32122916
[TBL] [Abstract][Full Text] [Related]
10. Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.
Fukuhara T; Wada M; Nakamura S; Ono C; Shiokawa M; Yamamoto S; Motomura T; Okamoto T; Okuzaki D; Yamamoto M; Saito I; Wakita T; Koike K; Matsuura Y
PLoS Pathog; 2014 Dec; 10(12):e1004534. PubMed ID: 25502789
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic tropism of hepatitis C virus infection].
Fukuhara T
Uirusu; 2018; 68(1):63-70. PubMed ID: 31105136
[TBL] [Abstract][Full Text] [Related]
12. HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit.
Vieyres G; Pietschmann T
Cells; 2019 Mar; 8(3):. PubMed ID: 30871009
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.
Pirro M; Bianconi V; Francisci D; Schiaroli E; Bagaglia F; Sahebkar A; Baldelli F
J Cell Mol Med; 2017 Dec; 21(12):3150-3161. PubMed ID: 28722331
[TBL] [Abstract][Full Text] [Related]
14. Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.
Lavie M; Dubuisson J
Biochimie; 2017 Oct; 141():62-69. PubMed ID: 28630011
[TBL] [Abstract][Full Text] [Related]
15. Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity.
Brault C; Lévy P; Duponchel S; Michelet M; Sallé A; Pécheur EI; Plissonnier ML; Parent R; Véricel E; Ivanov AV; Demir M; Steffen HM; Odenthal M; Zoulim F; Bartosch B
Gut; 2016 Jan; 65(1):144-54. PubMed ID: 25516417
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.
Crouchet E; Baumert TF; Schuster C
Expert Rev Proteomics; 2017 Jul; 14(7):593-606. PubMed ID: 28625086
[TBL] [Abstract][Full Text] [Related]
17. The Role of ApoE in HCV Infection and Comorbidity.
Gong Y; Cun W
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027190
[TBL] [Abstract][Full Text] [Related]
18. Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.
Crouchet E; Lefèvre M; Verrier ER; Oudot MA; Baumert TF; Schuster C
Gut; 2017 May; 66(5):896-907. PubMed ID: 27609828
[TBL] [Abstract][Full Text] [Related]
19. PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.
Bridge SH; Sheridan DA; Felmlee DJ; Crossey MM; Fenwick FI; Lanyon CV; Dubuc G; Seidah NG; Davignon J; Thomas HC; Taylor-Robinson SD; Toms GL; Neely RD; Bassendine MF
J Hepatol; 2015 Apr; 62(4):763-70. PubMed ID: 25463543
[TBL] [Abstract][Full Text] [Related]
20. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.
André P; Komurian-Pradel F; Deforges S; Perret M; Berland JL; Sodoyer M; Pol S; Bréchot C; Paranhos-Baccalà G; Lotteau V
J Virol; 2002 Jul; 76(14):6919-28. PubMed ID: 12072493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
